By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Nymox Pharmaceutical Corporation 

175 Bouchard, Suite 100

Dorval  Quebec  H9S 1B1  Canada
Phone: 514-636-3122 Fax:


SEARCH JOBS








Company News
Nymox Pharmaceutical (NYMX) Announces $1.07 Million Financing 12/19/2014 7:37:57 AM
Nymox Pharmaceutical (NYMX) Reports Third Quarter 2014 Financial Results 11/14/2014 8:23:09 AM
Nymox Pharmaceutical (NYMX) NX-1207 BPH Pivotal Phase 3 U.S. Studies NX02-0017 And NX02-0018 Fail To Meet Primary Efficacy Endpoints 11/3/2014 9:28:14 AM
Nymox Pharmaceutical (NYMX) Tanks As Lead Drug Fails To Meet Primary Endpoints In Two Large Studies 11/3/2014 5:50:43 AM
Nymox Pharmaceutical (NYMX) Announces Positive Prostate Cancer 8 Month Clinical Trial Results 9/10/2014 8:13:22 AM
Nymox Pharmaceutical (NYMX) Reports Second Quarter 2014 Financial Results 8/11/2014 7:52:01 AM
Press Release Issued Under The Early Warning System/Sale Of Shares Of Nymox Pharmaceutical (NYMX) 8/7/2014 7:35:45 AM
Nymox Pharmaceutical (NYMX) Announces Completion Of Enrollment For Second BPH Re-Injection Study 7/15/2014 9:16:16 AM
Nymox Pharmaceutical (NYMX) Reports Positive Update On Nerve Sparing And Sexual Function Preservation In Men Treated With NX-1207 6/17/2014 9:06:23 AM
Nymox Pharmaceutical (NYMX) Reports Positive New Safety Study Data For Phase 3 BPH Drug 6/12/2014 7:21:35 AM
12345678910...
//-->